Glucose Phosphate Isomerase
EmergingGPI deficiency is a rare glycolytic enzyme cause of hereditary hemolytic anemia, in the same family as pyruvate kinase deficiency.
This is one of several enzymes involved in how red blood cells make energy. A rare inherited shortage causes chronic anemia, in the same family of conditions as pyruvate kinase deficiency discussed earlier.
Glucose phosphate isomerase (GPI) is a glycolytic enzyme involved in red blood cell energy metabolism; its hereditary deficiency causes a rare form of non-spherocytic hemolytic anemia.
GPI deficiency impairs red blood cell energy production, leading to premature cell breakdown and chronic hemolytic anemia, following the same general pattern as the pyruvate kinase deficiency discussed earlier in this biomarker set.
Diagnosed via red blood cell enzyme activity assay after excluding more common causes of hemolytic anemia; genetic testing of the GPI gene can confirm diagnosis.
Management is primarily supportive (transfusions as needed, folic acid supplementation, splenectomy in select severe cases), similar to management of other glycolytic enzyme deficiencies in this biomarker set, since no enzyme-specific therapy exists.
Management is supportive, following the same general approach as other red cell enzyme deficiencies in this biomarker set.
- General hematology reference literature on glycolytic enzyme deficiencies causing hereditary non-spherocytic hemolytic anemia.